Visca P, Alò P L, Del Nonno F, Botti C, Trombetta G, Marandino F, Filippi S, Di Tondo U, Donnorso R P
Department of Cytopathology, Regina Elena National Cancer Institute of Rome, Italy.
Clin Cancer Res. 1999 Dec;5(12):4111-8.
The normal mucosa-adenoma-carcinoma sequence in colon pathology provides an attractive model of tumor progression. The role of tumor suppressor genes, oncogenes, and proliferative markers in tumorogenesis has evolved considerably in the last decade. By immunohistochemistry means, we have studied p53, bcl-2, c-myc, p21-ras, ki67, and fatty acid synthase (a fatty-acid-synthesizing enzyme) in normal, dysplastic, and neoplastic mucosa. The results were correlated with clinicopathological features and overall survival (OS). Formalin-fixed, paraffin-embedded archival material from 100 nonconsecutive adenomas and 100 adenocarcinomas (ADCs), including adjacent-to-tumor nonneoplastic mucosa (ANNM), from patients with a 5-year follow-up period were studied. Negative controls were obtained from colon resections for nonneoplastic disease. Fatty acid synthase was associated with ADC (P = 0.0001). p53 protein was associated with high-grade dysplasia adenoma (AHGD), ADC (P = 0.0001), and pT stage (P = 0.003). bcl-2 was associated with adenomas with low-grade dysplasia (P = 0.009); c-myc was associated with ANNM (P = 0.005) and pT stage (P = 0.006). p21-ras was associated with AHGD (P = 0.0001) and ANNM (P = 0.01). Ki67 was associated with AHGD (P = 0.02) and ADC (P = 0.0001). Univariate analysis on neoplastic tissue revealed histological grade, pT stage, pN stage, p21-ras, and p53 to be significant markers of OS; p21-ras, p53, and c-myc were reliable markers when evaluated on ANNM. Multivariate analysis revealed pT stage, pN stage, and p21-ras to be independent prognosticators of OS on ADC; p21-ras and c-myc staining in the ANNM were correlated with worse survival (OS). We suggest that the evaluation in concert of clinicopathological data and immunohistochemical markers on both normal and abnormal colon tissue provides an attractive model of tumor progression; moreover, it may give important messages about the prediction of survival.
结肠病理学中正常的黏膜-腺瘤-癌序列为肿瘤进展提供了一个有吸引力的模型。在过去十年中,肿瘤抑制基因、癌基因和增殖标志物在肿瘤发生中的作用有了很大的演变。通过免疫组织化学方法,我们研究了正常、发育异常和肿瘤性黏膜中的p53、bcl-2、c-myc、p21-ras、ki67和脂肪酸合酶(一种脂肪酸合成酶)。结果与临床病理特征和总生存期(OS)相关。研究了来自100例非连续性腺瘤和100例腺癌(ADCs)患者的福尔马林固定、石蜡包埋存档材料,包括肿瘤旁非肿瘤性黏膜(ANNM),这些患者有5年的随访期。阴性对照取自非肿瘤性疾病的结肠切除术。脂肪酸合酶与ADC相关(P = 0.0001)。p53蛋白与高级别发育异常腺瘤(AHGD)、ADC(P = 0.0001)和pT分期(P = 0.003)相关。bcl-2与低级别发育异常腺瘤相关(P = 0.009);c-myc与ANNM相关(P = 0.005)和pT分期(P = 0.006)。p21-ras与AHGD相关(P = 0.0001)和ANNM相关(P = 0.01)。Ki67与AHGD相关(P = 0.02)和ADC相关(P = 0.0001)。对肿瘤组织的单因素分析显示,组织学分级、pT分期、pN分期、p21-ras和p53是OS的重要标志物;在ANNM上评估时,p21-ras、p53和c-myc是可靠的标志物。多因素分析显示,pT分期、pN分期和p21-ras是ADC患者OS的独立预后因素;ANNM中p21-ras和c-myc染色与较差的生存期(OS)相关。我们认为,对正常和异常结肠组织的临床病理数据和免疫组织化学标志物进行联合评估提供了一个有吸引力的肿瘤进展模型;此外,它可能给出关于生存预测的重要信息。